AliveCor announced today that it received FDA clearance for the next generation of its AI technology for the Kardia 12L ECG ...

The newly cleared features include three rhythm modifiers and two axis-related morphology determinations: RAD and LAD.

AliveCor, the global leader in AI-powered cardiology, today announced it has received U.S. Food and Drug Administration (FDA) ...

AliveCor has spent years battling with Apple over the market for consumer heart monitoring technology. Now it’s hoping to make its imprint on professional health care with its new device, which ...

While Watch Series 4 and its successors will undoubtedly bring this life-saving technology to millions of people over the next several years, Apple was not the first to bring it to market. That ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Medable, Inc., the leading global platform for decentralized clinical trials, and AliveCor, the leader in AI-based, personal ECG technology, today announced a ...

Smartphone-connected ECG maker AliveCor is teaming up with the Mayo Clinic once again, this time to develop algorithms to screen for Long QT syndrome, a heart condition that can often cause sudden ...

Mountain View, California-based AliveCor, which makes an FDA-cleared mobile electrocardiogram (ECG) device and companion app collectively called Kardia Mobile, has released new features that make it ...

After Apple claimed its Apple Watch Series 4 would be the first FDA-cleared over-the-counter device with an electrocardiogram, AliveCor struck back, noting it obtained FDA clearance for similar ...

Health technology company AliveCor, maker of connected electrocardiogram devices, is trying to ban U.S. sales of the Apple Watch, claiming the tech giant allegedly infringed on three of its patents.

AliveCor, Inc., a company focused on cardiac data and remote medicine, successfully convinced an International Trade Commission (ITC) judge that Apple, Inc. infringed multiple AliveCor patents related ...